CD antigen CD38 is also known as ADPribosyl cyclase 1, which belongs to the ADPribosyl cyclase family. CD38 is expressed at high levels in pancreas, liver, kidney, brain, testis, ovary, placenta, malignant lymphoma and neuroblastoma. CD38 is a multifunctional ectoenzyme that catalyzes the synthesis and hydrolysis of cyclic ADPribose (cADPR) from NAD+ to ADPribose. These reaction products are essential for the regulation of intracellular Ca2+. The loss of CD38 function is associated with impaired immune responses, metabolic disturbances, and behavioral modifications. The CD38 protein is a marker of cell activation. It has been connected to HIV infection, leukemias, myelomas, solid tumors, type II diabetes mellitus and bone metabolism. CD38 has been used as a prognostic marker in leukemia. - Proteine/Peptide
Immobilized Anti-CD38 Antibody (Daratumumab), Human IgG1 at 2 µg/mL (100 µL/well) can bind FITC-Labeled Human CD38, Fc Tag (Cat. No. CD8-HF255) with a linear range of 0.078-0.625 µg/mL (QC tested).
Immobilized Monoclonal Anti-CD38 Antibody, Human IgG1 at 2 µg/mL (100 µL/well) can bind FITC-Labeled Human CD38, Fc Tag (Cat. No. CD8-HF255) with a linear range of 0.039-1.25 ug/mL (Routinely tested).
CD8-HF255-25ug
FITC-Labeled Human CD38, Fc Tag on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 90%.
* VAT and and shipping costs not included. Errors and price changes excepted
